Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Allurion Technologies, Inc. (ALUR) vs NeuroOne Medical Technologies Corporation (NMTC)

Allurion Technologies, Inc. and NeuroOne Medical Technologies Corporation are both Medical Devices companies. Allurion Technologies, Inc. is the larger, with a market value of $16.7M against $12.1M — 1.4× the size. NeuroOne Medical Technologies Corporation grew revenue faster over the last twelve months: −1.67% against −55.5%. NeuroOne Medical Technologies Corporation has the higher net margin (−78.6% vs −264.7%) and the lower return on invested capital (−287.1% vs 0.00%). Across the 15 metrics below, NeuroOne Medical Technologies Corporation leads on 11 and Allurion Technologies, Inc. on 4.

Valuation

Metric ALUR NMTC Medical Devices median
P/E n/m n/m 22.18
P/S 0.08 1.22 2.70
P/B n/m 3.06 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 5.33 1.00 2.38
Earnings yield (5,345.22%) (67.67%) (8.22%)
Free cash flow yield (2,358.12%) (62.16%) (7.80%)

Profitability

Metric ALUR NMTC Medical Devices median
Gross margin 52.70% 55.65% 56.01%
Operating margin (211.21%) (83.43%) (15.03%)
Net margin (264.74%) (78.63%) (20.40%)
Free cash flow margin (180.19%) (75.63%) (7.24%)
Return on equity 45.16% (124.66%) (15.32%)
Return on assets (127.26%) (87.56%) (19.72%)
Return on invested capital 0.00% (287.08%) (10.33%)

Growth

Metric ALUR NMTC Medical Devices median
Revenue growth (TTM) (55.49%) (1.67%) 8.80%
EPS growth (last fiscal year) (18.97%) 80.43% —
Revenue growth, 5-year CAGR — 44.41% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALUR NMTC Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 0.30 2.84 2.50
Net debt to EBITDA 0.19 1.74 0.49

Dividend

Metric ALUR NMTC Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric ALUR NMTC Medical Devices median
Market cap 16.70m 12.11m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack